Antipsychotic-Induced Sexual Dysfunction and Its Management.
10.5534/wjmh.2012.30.3.153
- Author:
Yeon Won PARK
1
;
Yooseok KIM
;
Jun Ho LEE
Author Information
1. Department of Urology, National Police Hospital, Seoul, Korea. bonanza96@hanmail.net
- Publication Type:Review
- Keywords:
Sexual dysfunction;
Antipsychotic agents;
Management
- MeSH:
Antipsychotic Agents;
Benzodiazepines;
Clozapine;
Compliance;
Dibenzothiazepines;
Haloperidol;
Humans;
Hyperprolactinemia;
Piperazines;
Purines;
Quinolones;
Receptors, Dopamine D2;
Risperidone;
Stress, Psychological;
Sulfones;
Sulpiride;
Thiazoles;
Aripiprazole;
Quetiapine Fumarate;
Sildenafil Citrate
- From:The World Journal of Men's Health
2012;30(3):153-159
- CountryRepublic of Korea
- Language:English
-
Abstract:
Sexual dysfunction is a common condition in patients taking antipsychotics, and is the most bothersome symptom and adverse drug effect, resulting in a negative effect on treatment compliance. It is known that hyperprolactinemia is a major cause of sexual dysfunction. Based on the blockade of dopamine D2 receptors, haloperidol, risperidone, and amisulpride are classed as prolactin-elevating antipsychotics, while olanzapine, clozapine, quetiapine, ziprasidone, and aripiprazole are classed as prolactin-sparing drugs. Risperidone and the other typical antipsychotics are associated with a high rate of sexual dysfunction as compared to olanzapine, clozapine, quetiapine, and aripiprazole. With regard to treatment in patients suffering from sexual dysfunction, sildenafil was associated with significantly more erections sufficient for penetration as compared to a placebo. Subsequent studies are needed in order to provide physicians with a better understanding of this problem, thereby leading toward efficacious and safe solutions.
